M&A Transaction Multiples - Biofac Esbjerg

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

__________________________________

This report is accessible on EMAT, the reference database for private company acquisition multiples

► Subscribe to EMAT database

► Sectors covered by our analysts

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

► Buy Full EMAT Report

Price: €120

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

► Example of EMAT Report

EPSILON M&A DEAL REPORT

Transaction Multiples for the Valuation of Private Companies

Zeria Pharmaceutical Co / Biofac Esbjerg

No EMAT : 21973

Announced Date : 07/09/2010

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Zeria Pharmaceutical Co

Target : Biofac Esbjerg

Country : Denmark

Sector of activity :

Chemicals > Specialty Chemicals
Health, Pharmaceuticals & Biotechnology > Pharmaceuticals & Cosmetics > Pharmaceuticals
Food & Beverage > Food Producers > Food Complements

Business Description :

Biofac Esbjerg As manufactures and sales chondroitin, a raw material for use in drugs . It manufactures high-quality sodium chondroitin sulfate using a unique proprietary production technology and...

Transaction multiples available

	EV/ Sales	EV/ Gross Profit	EV/ EBITDA	EV/ EBIT	Eq/ PBT	P/E	Price to Book	Specific multiple(s)
Historic		-	-	-	-			-
Current	-	-	-	-	-	-

Rating :

	Multiple available
n.s.	Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports / sub-sector « Specialty Chemicals » = 60
Number of EMAT Reports / sub-sector « Pharmaceuticals » = 65
Number of EMAT Reports / sub-sector « Food Complements » = 44

Example of comparable transactions on EMAT (same sub-sector):

11/11/2010

Meda

Three Over the Counter OTC Products

Netherlands

21980

03/06/2010

BeCapital Private Equity

Laboratoires Goëmar

France

22192

Source: Epsilon Research / EMAT